These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 29698921)
21. Synthesis, Antitumor Evaluation, Molecular Modeling and Quantitative Structure-Activity Relationship (QSAR) of Novel 2-[(4-Amino-6- Tomorowicz Ł; Sławiński J; Żołnowska B; Szafrański K; Kawiak A Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331219 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, Molecular Structure, Anticancer Activity, and QSAR Study of Żołnowska B; Sławiński J; Brzozowski Z; Kawiak A; Belka M; Zielińska J; Bączek T; Chojnacki J Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772699 [TBL] [Abstract][Full Text] [Related]
23. Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability. Sławiński J; Szafrański K; Pogorzelska A; Żołnowska B; Kawiak A; Macur K; Belka M; Bączek T Eur J Med Chem; 2017 May; 132():236-248. PubMed ID: 28364658 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety. Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528 [TBL] [Abstract][Full Text] [Related]
25. Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines. Lad NP; Kulkarni S; Sharma R; Mascarenhas M; Kulkarni MR; Pandit SS Eur J Med Chem; 2017 Jan; 126():870-878. PubMed ID: 27987486 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents. Poudapally S; Battu S; Velatooru LR; Bethu MS; Janapala VR; Sharma S; Sen S; Pottabathini N; Iska VBR; Katangoor V Bioorg Med Chem Lett; 2017 May; 27(9):1923-1928. PubMed ID: 28351589 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)nicotinamides as potential anticancer agents that inhibit tubulin polymerization. Kamal A; Reddy NV; Nayak VL; Bolla NR; Subba Rao AV; Prasad B Bioorg Med Chem; 2014 Jul; 22(13):3465-77. PubMed ID: 24835786 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents. Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, QSAR studies, and metabolic stability of novel 2-alkylthio-4-chloro-N-(5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)benzenesulfonamide derivatives as potential anticancer and apoptosis-inducing agents. Żołnowska B; Sławiński J; Pogorzelska A; Szafrański K; Kawiak A; Stasiłojć G; Belka M; Zielińska J; Bączek T Chem Biol Drug Des; 2017 Sep; 90(3):380-396. PubMed ID: 28122174 [TBL] [Abstract][Full Text] [Related]
30. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents. Ahmadi S; Habibpour E Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182 [TBL] [Abstract][Full Text] [Related]
31. Arylsulfonyl-N,N-diethyl-dithiocarbamates: a novel class of antitumor agents. Scozzafava A; Mastrolorenzo A; Supuran CT Bioorg Med Chem Lett; 2000 Aug; 10(16):1887-91. PubMed ID: 10969992 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents. Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors. Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284 [TBL] [Abstract][Full Text] [Related]
34. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Szafrański K; Vullo D; Supuran CT Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761 [TBL] [Abstract][Full Text] [Related]
35. Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents. Mehndiratta S; Chiang YF; Lai MJ; Lee HY; Chen MC; Kuo CC; Chang CY; Chang JY; Liou JP Bioorg Med Chem; 2014 Sep; 22(17):4917-23. PubMed ID: 25059503 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives. Marciniec K; Pawełczak B; Latocha M; Skrzypek L; Maciążek-Jurczyk M; Boryczka S Molecules; 2017 Feb; 22(2):. PubMed ID: 28212337 [TBL] [Abstract][Full Text] [Related]
37. Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase. Debbabi KF; Al-Harbi SA; Al-Saidi HM; Aljuhani EH; Abd El-Gilil SM; Bashandy MS J Enzyme Inhib Med Chem; 2016; 31(sup4):7-19. PubMed ID: 27557134 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety. Ghorab MM; Ragab FA; Hamed MM Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of 2-phenylquinoline-4-carboxamide derivatives as a new class of tubulin polymerization inhibitors. Zhu L; Luo K; Li K; Jin Y; Lin J Bioorg Med Chem; 2017 Nov; 25(21):5939-5951. PubMed ID: 28988750 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of novel substituted pyrimidine derivatives bearing a sulfamide group and their in vitro cancer growth inhibition activity. Lefebvre CA; Forcellini E; Boutin S; Côté MF; C-Gaudreault R; Mathieu P; Lagüe P; Paquin JF Bioorg Med Chem Lett; 2017 Jan; 27(2):299-302. PubMed ID: 27903409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]